Breaking News Instant updates and real-time market news.

NFLX

Netflix

$338.24 /

-1.32 (-0.39%)

07:28
01/22/20
01/22
07:28
01/22/20
07:28

Netflix U.S. subscriber miss more troubling than it appears, says Needham

Needham analyst Laura Martin keeps her Underperform rating on Netflix after its Q4 results, noting that the company's U.S. subscriber net adds of 402K - below the guided 600K were more troubling than they appear. The analyst notes that while the company cited 2019's price increases and churn in homes with children, the quarter had a strong slate of content with 8 films with 24 Academy Award nominations as well as the price competition with Disney+ only coming in December, since that offering was free for the first 30 days. Martin further points to Netflix's marketing expenses rising to 16% of revenue in Q4 vs. 13% average in 2019 and 11% in Q3. The analyst adds that the company's international growth also has some issues, since U.S. subscribers have historically been 3-times more profitable than its international ones.

NFLX Netflix
$338.24 /

-1.32 (-0.39%)

01/22/20 Canaccord
Netflix softer outlook reflects elevated churn trends in US, says Canaccord
01/22/20 Wells Fargo
Tempering of expectations could make Netflix 'a tough stock,' says Wells Fargo
01/22/20 UBS
Netflix price target lowered to $400 from $405 at UBS
01/22/20 RBC Capital
Netflix Q4 fundamentals were strong, says RBC Capital

TODAY'S FREE FLY STORIES

Options
Skechers put volume heavy and directionally bearish » 13:55
02/25/20
02/25
13:55
02/25/20
13:55
SKX

Skechers

$33.10 /

-1.04 (-3.05%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury Action: the front end of the market flinched slightly » 13:55
02/25/20
02/25
13:55
02/25/20
13:55

Treasury Action: the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Kudlow says long-term investors should take 'serious look' at stock market here » 13:47
02/25/20
02/25
13:47
02/25/20
13:47
SPY

SPDR S&P 500 ETF Trust

$316.19 /

-6.24 (-1.94%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

The stock market is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Ally Financial call volume above normal and directionally bullish » 13:45
02/25/20
02/25
13:45
02/25/20
13:45
ALLY

Ally Financial

$26.34 /

-1.07 (-3.90%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Kudlow says 'not hearing' about any emergency rate cut from Fed » 13:44
02/25/20
02/25
13:44
02/25/20
13:44
SPY

SPDR S&P 500 ETF Trust

$316.70 /

-5.73 (-1.78%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Larry Kudlow, asked about…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. health leaders doing 'exactly what they should be doing,' Kudlow says » 13:39
02/25/20
02/25
13:39
02/25/20
13:39
SPY

SPDR S&P 500 ETF Trust

$316.55 /

-5.885 (-1.83%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

National Economic Council…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Wolfe Research tech strategist to hold an analyst/industry webcast » 13:36
02/25/20
02/25
13:36
02/25/20
13:36
AAPL

Apple

$294.22 /

-3.94 (-1.32%)

Tech Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Kudlow says 'not at all convinced' U.S. can't get hold of what it needs » 13:36
02/25/20
02/25
13:36
02/25/20
13:36
SPY

SPDR S&P 500 ETF Trust

$316.46 /

-5.97 (-1.85%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Speaking about the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FHFA Director says Fannie, Freddie sahreholders will be 'heavily diluted' » 13:36
02/25/20
02/25
13:36
02/25/20
13:36
FNMA

Fannie Mae

$0.00 /

+ (+0.00%)

, FMCC

Freddie Mac

$0.00 /

+ (+0.00%)

Federal Housing Finance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
BTIG healthcare analysts to hold an analyst/industry conference call » 13:35
02/25/20
02/25
13:35
02/25/20
13:35
STAA

Staar Surgical

$30.52 /

-1.06 (-3.36%)

Healthcare Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Hilton put volume heavy and directionally bearish » 13:35
02/25/20
02/25
13:35
02/25/20
13:35
HLT

Hilton

$100.57 /

-3.445 (-3.31%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Kudlow says U.S. has contained coronavirus 'pretty close to airtight' » 13:34
02/25/20
02/25
13:34
02/25/20
13:34
SPY

SPDR S&P 500 ETF Trust

$316.44 /

-5.99 (-1.86%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Kudlow says, while a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: EUR-USD » 13:30
02/25/20
02/25
13:30
02/25/20
13:30

FX Action: EUR-USD…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Treasury $40 B 2-year auction stats were relatively disappointing » 13:30
02/25/20
02/25
13:30
02/25/20
13:30

Treasury $40 B 2-year…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Wedbush pharma/biotech analysts to hold an analyst/industry conference call » 13:29
02/25/20
02/25
13:29
02/25/20
13:29

Emerging Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Zynga call volume above normal and directionally bullish » 13:25
02/25/20
02/25
13:25
02/25/20
13:25
ZNGA

Zynga

$7.03 /

+0.005 (+0.07%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
House Energy & Commerce Committee to hold a hearing » 13:25
02/25/20
02/25
13:25
02/25/20
13:25

The Health Subcommittee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
FDANews to hold a webinar » 13:25
02/25/20
02/25
13:25
02/25/20
13:25

Jennifer Diaz, an expert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Wolfe Research tech strategist to hold an analyst/industry webcast » 13:25
02/25/20
02/25
13:25
02/25/20
13:25

Tech Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Iovance trading resumes, shares up 19% $29.41 after Bloomberg report  13:24
02/25/20
02/25
13:24
02/25/20
13:24
IOVA

Iovance Biotherapeutics

$24.75 /

+0.06 (+0.24%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Norwegian Cruise Line participates in a conference call with Wedbush » 13:23
02/25/20
02/25
13:23
02/25/20
13:23
NCLH

Norwegian Cruise Line

$40.32 /

-2.3 (-5.40%)

Leisure Analyst Hardiman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Iovance Biotherapeutics trading resumes  13:22
02/25/20
02/25
13:22
02/25/20
13:22
IOVA

Iovance Biotherapeutics

$24.68 /

-0.01 (-0.04%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Iovance Biotherapeutics jumps 11% after Bloomberg says exploring sale » 13:21
02/25/20
02/25
13:21
02/25/20
13:21
IOVA

Iovance Biotherapeutics

$24.68 /

-0.01 (-0.04%)

Shares of Iovance…

Shares of Iovance Biotherapeutics jumped, then halted for volatility, after Ed Hammond and Nabila Ahmed of Bloomberg reported that the company is exploring a sale and has held preliminary talks with potential buyers. Iovance is working with a financial adviser after receiving takeover interest, a source told Bloomberg. Iovance shares jumped 11%, or $2.63, to $27.32 following the report, triggering a halt for volatility.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Iovance Biotherapeutics exploring potential sale, Bloomberg reports  13:18
02/25/20
02/25
13:18
02/25/20
13:18
IOVA

Iovance Biotherapeutics

$24.68 /

-0.01 (-0.04%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Iovance Biotherapeutics trading halted, volatility trading pause  13:17
02/25/20
02/25
13:17
02/25/20
13:17
IOVA

Iovance Biotherapeutics

$24.61 /

-0.08 (-0.32%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.